Originally approved for an orphan disease, Glivec now has over 9 approvals and is a billion dollar product. Could another approval for diabetes further increase the commercial potential of this drug?
Monthly Archives: May 2009
Uncategorised
About/subscribe
You can subscribe to the newsletter here. The Numedicus blog aims to discuss all things relevant to drug repurposing/therapeutic switching. Numedicus is found on the web at http://www.numedicus.co.uk. It is written by David Cavalla, whose picture and brief biographical details are found here.